AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder

N-MOmentum study investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences